Pharmacology of sodium cromoglycate

Clinical and Experimental Allergy, Supplement

Volumn 26, Issue 4, 1996, Pages 5-7

  Norris, A A ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE CHANNEL; CROMOGLYCATE DISODIUM; HISTAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ASTHMA; CHEMOTAXIS; EOSINOPHIL; HUMAN; MAST CELL; NEUTROPHIL; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; ASTHMA; BRONCHOCONSTRICTION; CHEMOTAXIS, LEUKOCYTE; CROMOLYN SODIUM; EOSINOPHILS; HISTAMINE RELEASE; NEUTROPHILS;

EID: 0029898310     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (28)

1. Foreman JC, Hallet MB, Mongar JL. Site of action of the antiallergic drugs cromoglycate and doxantrazole. Br J Pharmacol 1977; 59:473P.
2. Theoharides TC, Sieghart W, Greengard P, Douglas WW. Antiallergic drug cromolyn may inhibit histamine secretion by regulating phosphorylation of a mast cell protein. Science 1980; 207:80-2.
3. Wells E, Mann J. Phosphorylation of a mast cell protein in response to treatment with anti-allergic compounds. Biochem Pharmac 1983; 32:837-42.
4. Mackay G, Pearce F. Extracellular cGMP has a spectrum of activity in rodent isolated mast cells similar to that of sodium cromoglycate. Br J Pharmacol 1993; 109:65P.
5. Beaven MA, Rogers J, Moore JP et al. The mechanism of the calcium signal and correlation with histamine release in 2H3 cells. J Biol Chem 1984; 259:7129-36.
6. Penner R, Matthews G, Neher E. Regulation of calcium influx by second messengers in rat mast cells. Nature 1988; 334:499-504.
7. Friis U, Johansen T, Hayes N, Foreman J. IgE-receptor activated chloride uptake in relation to histamine secretion from rat mast cells. Br J Pharmacol 1994; 111:1179-83.
8. Romanin C, Reinsprecht M, Pecht I, Schindler, H. Immunologically activated chloride channels involved in degranulation of rat mucosal mast cells. EMBO J 1991; 10:3606-8.
9. Reinsprecht M, Pecht I, Schindler H, Romanin C. Potent block of Cl-channels by anti-allergic drugs. Biochem Biophys Res Comm 1992; 188:957-63.
10. Paulmichl M, Li Y, Wickman K et al. New mammalian chloride channel identified by expression cloning. Nature 1992; 356:238-41.
11. Orr TSC, Cox JSG. Disodium cromoglycate, an inhibitor of mast cell degranulation and histamine release induced by phospholipase A. Nature (London) 1969; 223:197-8.
12. Leung KBP, Flint KC, Brostoff J et al. Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells. Thorax 1988; 43:756-61.
13. Bissonnette EY, Befus AD. Modulation of mast cell function in the GI tract. Handbook of Immunopharmacology: Gastrointestinal System. New York, London: Academic Press 1993.
14. Bruijnzeel PLB, Warringa RAJ, Kok PTM, Kreukniet J. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate. Br J Pharmacol 1990; 99: 798-802.
15. Kay AB, Walsh GM, Moqbel R et al. Disodium cromoglycate inhibits activation of human inflammatory cells in vitro. J All Clin Immunol 1987; 80:1-8.
16. Rand TH, Lopez AF, Gamble JR, Vadas MA. Nedocromil sodium and cromolyn (sodium cromoglycate) selectively inhibit antibody-dependent granulocyte-mediated cytotoxicity. Int Arch All Appl Immunol 1988; 87:151-8.
17. Dixon M, Jackson DM, Richards IM. The action of sodium cromoglycate on 'C'-fibre endings in the dog lung. Br J Pharmacol 1980; 70:11-13.
18. Dixon M, Jackson DM, Richards IM. The effects of histamine, acetylcholine and 5-hydroxytryptamine on lung mechanics and irritant receptors in the dog. J Physiol 1979; 287:393-403.
19. Ben-Dov I, Bar-Yishay B, Godfrey S. Heterogeneity in the response to pre-exercise treatment with cromolyn sodium. Am Rev Resp Dis 1983; 127:113-16.
20. Norris AA, Leeson ML, Jackson DM, Holroyde MC. Modulation of neurogenic inflammation in rat trachea. Pulmonary Pharmacol 1990; 3:180-4.
21. Kimata H, Yoshida A, Ishioka C, Mikawa H. Disodium cromoglycate (DSCG) selectively inhibits IgE production and enhances IgG4 production by human B cells in vitro. Clin Exp Immunol 1991; 84:395-9.
22. Loh RKS, Jabara HH, Geha RS. Disodium cromoglycate inhibits Sμ to Se deletional switch recombination and IgE synthesis in human B cells. J Exp Med 1994; 180:663-71.
23. Diaz P, Galleguillos FR, Gonzalez MC et al. Bronchoalveolar lavage in asthma: the effect of disodium cromoglycate (cromolyn) on leukocyte counts, immunoglobulins and complement. J All Clin Immunol 1984; 74:41-8.
24. Edwards A. Sodium cromoglycate (Intal) as an anti-inflammatory agent for the treatment of chronic asthma. Clin Exp Allergy 1994; 24:612-23.
25. Cockcroft DW, Murdock KW. Comparative effects of inhaled salbutamol, sodium cromoglycate and beclomethasone on allergen-induced early asthmatic responses and increased bronchial responsiveness to histamine. J All Clin Immunol 1987; 79:734-40.
26. Allegra L, Bianca S. Non-specific bronchoreactivity obtained with an ultrasonic aerosol of distilled water. Eur J Resp Dis 1980; 61:41-9.
27. Black JL, Smith CM, Anderson SD. Cromolyn sodium inhibits the increased responsiveness to methacholine that follows ultrasonically nebulised water challenge in patients with asthma. J All Clin Immunol 1987; 80:39-44.
28. Anderson SD, du Toit JI, Rodwell LT, Jenkins CR. Acute effect of sodium cromoglycate on airway narrowing induced by 4.5% saline aerosol. Chest 1994; 105:673-80.